7-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one, 95.0%, 2.5g

2-(4-Chloro-3-methoxyphenyl)acetonitrile, 95.0%, 1g

8-Bromo-6-fluoro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 97.0%, 100mg

7-Fluoro-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione, 95.0%, 100mg

3-Phenylphthalide, 98.0%, 5g

Ethyl bromofluoroacetate, 97.0%, 25g

3',5'-dichloro-3-(4-thiomethylphenyl)propiophenone, 97.0%, 1g

4-Amino-3-chlorophenylacetylene, 500mg

Tert-butyl3-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]azetidine-1-carboxylate, 98%, 100mg

(S)-3-(Aminomethyl)-1-N-Boc-pyrrolidine, 97.0%, 10g

Filtres pour seringues ROTILABO® Mini-Tip Polytétrafluoroéthylène (PTFE), 0,45 µm, 100 Pièce(s)

3-Methoxysalicylic Acid>98.0%(GC)(T)5g

Objetivo IOS Plan PLi S100x/1.25 de inmersión en aceite con corrección infinita. Distancia de trabajo 0,36 mm